Assessment of outcomes and biomarkers in colorectal cancer
Prospective, Population-based Cohort Collection of Blood Samples and Tumor Tissue From Patients Operated on for Primary or Metastatic Colorectal Cancer
This study is trying to see how well surgery works for people with colorectal cancer and if certain blood and tissue markers can help predict their outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Helse Stavanger HF Government |
| Locations | 1 site (Stavanger) |
| Trial ID | NCT01762813 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on the clinical outcomes of surgical management for patients with primary and metastatic colorectal cancer. It involves the prospective collection of tissue samples to explore potential biomarkers in blood and tumor tissues. The study aims to assess clinical outcomes through molecular profiling and patient-reported outcomes, providing insights into the effectiveness of surgical interventions. Data will be gathered to understand the relationship between clinical pathways and patient results.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older diagnosed with primary or metastatic colorectal cancer who are planning to undergo curative surgery.
Not a fit: Patients who are unable to provide informed consent or those not planning to undergo surgical treatment for their colorectal cancer may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of colorectal cancer management and improve patient outcomes through personalized treatment approaches.
How similar studies have performed: Other studies have shown promise in using biomarker analysis for colorectal cancer, indicating that this approach has potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of colorectal cancer, primary or metastatic (liver), with a treatment intention of planned curative surgery * Informed consent to participate * Age ≥18 Exclusion Criteria: * failure to provide written informed consent
Where this trial is running
Stavanger
- Stavanger University Hospital — Stavanger, Norway (Recruiting)
Study contacts
- Principal investigator: Kjetil Søreide, MD, PhD, FRCS, FACS — Helse Stavanger HF
- Study coordinator: Ramesh L. Kajavi, RN
- Email: acro.gitan@gmail.com
- Phone: 92297672
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.